|
KR20170091770A
(ko)
|
2006-07-10 |
2017-08-09 |
파이온 유케이 리미티드 |
속효형 벤조디아제핀 염 및 이의 중합체 형태
|
|
WO2011054845A1
(en)
*
|
2009-11-05 |
2011-05-12 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
EP2902030B1
(en)
|
2010-05-14 |
2016-09-14 |
Dana-Farber Cancer Institute, Inc. |
Thienotriazolodiazepine compounds for treating neoplasia
|
|
BR112012029057A2
(pt)
|
2010-05-14 |
2020-10-13 |
Dana-Farber Cancer Institute, Inc. |
composições e métodos de tratamento de leucemia
|
|
CA2799381A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Male contraceptive compositions and methods of use
|
|
JP5715241B2
(ja)
*
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
|
EP2450039A1
(en)
|
2010-11-08 |
2012-05-09 |
PAION UK Ltd. |
Dosing regimen for sedation with CNS 7056 (Remimazolam)
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9422292B2
(en)
|
2011-05-04 |
2016-08-23 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
WO2012174487A2
(en)
|
2011-06-17 |
2012-12-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
*
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013033268A2
(en)
*
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
EP2838881B1
(en)
|
2012-04-20 |
2018-08-08 |
AbbVie Inc. |
Isoindolone derivatives
|
|
UA115063C2
(uk)
*
|
2012-05-22 |
2017-09-11 |
ПАЙОН ЮКей ЛІМІТЕД |
Композиції, які містять бензодіазепіни короткої дії
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
EP2864336B1
(en)
|
2012-06-06 |
2016-11-23 |
Constellation Pharmaceuticals, Inc. |
Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
KR20150023722A
(ko)
|
2012-06-12 |
2015-03-05 |
애브비 인코포레이티드 |
피리디논 및 피리다지논 유도체
|
|
US9890147B2
(en)
|
2012-08-16 |
2018-02-13 |
Bayer Pharma Aktiengesellshaft |
2,3-benzodiazepines
|
|
CN104582708A
(zh)
*
|
2012-08-16 |
2015-04-29 |
葛兰素史克有限责任公司 |
用于治疗小细胞肺癌的苯并二氮*类
|
|
ES2625959T3
(es)
*
|
2012-09-28 |
2017-07-21 |
Bayer Pharma Aktiengesellschaft |
5-Aril-triazolo-azepinas inhibidoras de la proteína BET
|
|
CA2895905A1
(en)
|
2012-12-21 |
2014-06-26 |
Zenith Epigenetics Corp. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
AR094963A1
(es)
|
2013-03-04 |
2015-09-09 |
Ono Pharmaceutical Co |
Reacción de oxidación excelente en el índice de conversión
|
|
AU2014249192B2
(en)
|
2013-03-11 |
2017-12-21 |
The Regents Of The University Of Michigan |
BET bromodomain inhibitors and therapeutic methods using the same
|
|
EP2970285B1
(en)
*
|
2013-03-11 |
2019-04-17 |
AbbVie Inc. |
Fused tetracyclic bromodomain inhibitors
|
|
CN105026403B
(zh)
*
|
2013-03-12 |
2018-05-18 |
艾伯维公司 |
四环布罗莫结构域抑制剂
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
KR20150135359A
(ko)
|
2013-03-14 |
2015-12-02 |
컨버진 엘엘씨 |
브로모도메인-함유 단백질의 억제를 위한 방법 및 조성물
|
|
SG10201707487VA
(en)
|
2013-03-15 |
2017-10-30 |
Incyte Corp |
Tricyclic heterocycles as bet protein inhibitors
|
|
JP6388915B2
(ja)
|
2013-04-26 |
2018-09-12 |
ベイジーン，リミテッド |
置換５−（３，５−ジメチルイソオキサゾール−４−イル）インドリン−２−オン
|
|
CN104146970A
(zh)
*
|
2013-05-05 |
2014-11-19 |
王元青 |
治疗精神疾病的冻干粉针剂
|
|
CN103202815B
(zh)
*
|
2013-05-05 |
2014-09-24 |
李友香 |
治疗精神疾病的注射剂
|
|
NZ714669A
(en)
|
2013-06-21 |
2021-07-30 |
Zenith Epigenetics Ltd |
Novel bicyclic bromodomain inhibitors
|
|
JP6461118B2
(ja)
|
2013-06-21 |
2019-01-30 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての新規の置換された二環式化合物
|
|
WO2015006193A1
(en)
|
2013-07-08 |
2015-01-15 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
EA201690087A1
(ru)
|
2013-07-31 |
2016-08-31 |
Зенит Эпидженетикс Корп. |
Новые квиназолиноны как ингибиторы бромодомена
|
|
US11446309B2
(en)
|
2013-11-08 |
2022-09-20 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
|
|
WO2015081203A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
US9315501B2
(en)
|
2013-11-26 |
2016-04-19 |
Incyte Corporation |
Bicyclic heterocycles as BET protein inhibitors
|
|
GB201320994D0
(en)
*
|
2013-11-28 |
2014-01-15 |
Univ Dundee |
Enzyme function probes
|
|
WO2015095492A1
(en)
|
2013-12-19 |
2015-06-25 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
RU2016134947A
(ru)
|
2014-01-31 |
2018-03-01 |
Дана-Фарбер Кансер Институт, Инк. |
Производные диаминопиримидин бензолсульфона и их применение
|
|
MX2016009976A
(es)
|
2014-01-31 |
2016-11-15 |
Dana Farber Cancer Inst Inc |
Derivados de diazepam y sus usos.
|
|
JP2017504651A
(ja)
|
2014-01-31 |
2017-02-09 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
ジアゼパン誘導体の使用
|
|
CN106459056A
(zh)
|
2014-02-10 |
2017-02-22 |
康塞特医药品公司 |
经取代的三唑苯二氮卓
|
|
CN107074861A
(zh)
|
2014-02-28 |
2017-08-18 |
密执安大学评议会 |
作为bet溴结构域抑制剂的9h嘧啶并[4，5‑b]吲哚和相关类似物
|
|
WO2015131113A1
(en)
|
2014-02-28 |
2015-09-03 |
Tensha Therapeutics, Inc. |
Treatment of conditions associated with hyperinsulinaemia
|
|
US9884874B2
(en)
|
2014-04-09 |
2018-02-06 |
Kainos Medicine, Inc. |
Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer
|
|
SG11201608843TA
(en)
|
2014-04-23 |
2016-11-29 |
Incyte Corp |
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS
|
|
CA2952526A1
(en)
*
|
2014-06-18 |
2015-12-23 |
Bayer Pharma Aktiengesellschaft |
Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groups
|
|
EP3157928B1
(en)
|
2014-06-20 |
2019-02-13 |
Constellation Pharmaceuticals, Inc. |
Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
|
|
JP2017525759A
(ja)
|
2014-08-08 |
2017-09-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
ジヒドロプテリジノン誘導体およびその使用
|
|
JP2017526741A
(ja)
|
2014-08-08 |
2017-09-14 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
ジアゼパン誘導体およびその使用
|
|
WO2016044130A1
(en)
|
2014-09-15 |
2016-03-24 |
Incyte Corporation |
Tricyclic heterocycles for use as bet protein inhibitors
|
|
RU2697393C2
(ru)
*
|
2014-10-02 |
2019-08-14 |
ГлаксоСмитКлайн Интеллекчуал Проперти (N 2) Лимитед |
Кристаллическая твердая форма соли бензолсульфоновой кислоты и 2-[(4S)-6-(4-хлорфенил)-1-метил-8-(метилокси)-4H-[1,2,4]триазоло[4,3-a][1,4]бензодиазепин-4-ил]-N-этилацетамида, способ ее получения и фармацевтическая композиция, содержащая ее
|
|
WO2016069578A1
(en)
|
2014-10-27 |
2016-05-06 |
Tensha Therapeutics, Inc. |
Bromodomain inhibitors
|
|
WO2016087936A1
(en)
|
2014-12-01 |
2016-06-09 |
Zenith Epigenetics Corp. |
Substituted pyridinones as bromodomain inhibitors
|
|
CA2966303A1
(en)
|
2014-12-01 |
2016-06-09 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
CA2966449A1
(en)
|
2014-12-11 |
2016-06-16 |
Zenith Epigenetics Ltd. |
Substituted heterocycles as bromodomain inhibitors
|
|
CN107406438B
(zh)
|
2014-12-17 |
2021-05-14 |
恒翼生物医药科技(上海)有限公司 |
溴结构域的抑制剂
|
|
EP3262045A1
(en)
|
2015-02-27 |
2018-01-03 |
The Regents of The University of Michigan |
9h-pyrimido [4,5-b]indoles as bet bromodomain inhibitors
|
|
GB201504694D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Covalent conjugates
|
|
EP3277286B1
(en)
|
2015-03-31 |
2021-04-21 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
WO2016171470A1
(en)
*
|
2015-04-21 |
2016-10-27 |
Kainos Medicine, Inc. |
Bromodomain-inhibiting compounds and methods to prevent or treat a cancer
|
|
WO2016196065A1
(en)
|
2015-05-29 |
2016-12-08 |
Genentech, Inc. |
Methods and compositions for assessing responsiveness of cancers to bet inhibitors
|
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
MA42249A
(fr)
|
2015-06-26 |
2018-05-02 |
Tensha Therapeutics Inc |
Traitement de carcinome de la ligne médiane nut
|
|
JP6765622B2
(ja)
|
2015-07-17 |
2020-10-07 |
日本光電工業株式会社 |
救命支援装置
|
|
AU2016297024B2
(en)
|
2015-07-22 |
2021-03-04 |
Enanta Pharmaceuticals, Inc. |
Benzodiazepine derivatives as RSV inhibitors
|
|
RU2750164C2
(ru)
|
2015-09-11 |
2021-06-22 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Цианотиенотриазолодиазепины и пути их применения
|
|
BR112018004617A2
(pt)
|
2015-09-11 |
2018-09-25 |
Dana Farber Cancer Inst Inc |
acetamida tienotriazoldiazepinas e usos das mesmas
|
|
US20170121347A1
(en)
|
2015-10-29 |
2017-05-04 |
Incyte Corporation |
Amorphous solid form of a bet protein inhibitor
|
|
CR20180336A
(es)
|
2015-11-25 |
2018-08-06 |
Dana Farber Cancer Inst Inc |
Inhibidores de bromodominio bivalentes y usos de los mismos
|
|
CN106892924B
(zh)
*
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
|
EP3402799B1
(en)
|
2016-01-15 |
2022-05-04 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as rsv inhibitors
|
|
WO2017142881A1
(en)
|
2016-02-15 |
2017-08-24 |
The Regents Of The University Of Michigan |
Fused 1,4-oxazepines and related analogs as bet bromodomain inhibitors
|
|
CA3020281A1
(en)
|
2016-04-06 |
2017-10-12 |
The Regents Of The University Of Michigan |
Monofunctional intermediates for ligand-dependent target protein degradation
|
|
US11192898B2
(en)
|
2016-04-06 |
2021-12-07 |
The Regents Of The University Of Michigan |
MDM2 protein degraders
|
|
RU2752677C2
(ru)
|
2016-04-12 |
2021-07-29 |
Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган |
Деструкторы белка вет
|
|
MA44674B1
(fr)
|
2016-04-15 |
2020-06-30 |
Abbvie Inc |
Inhibiteurs de bromodomaine
|
|
WO2017189663A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2017189651A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2017189652A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
DE102017005089A1
(de)
|
2016-05-30 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Substitulerte 3,4-Dihydrochinoxalin-2(1H)-one
|
|
DE102017005091A1
(de)
|
2016-05-30 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Substituierte 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one
|
|
IL263824B2
(en)
|
2016-06-20 |
2023-10-01 |
Incyte Corp |
Crystals in solid form in the presence of an inhibitor
|
|
CN107629057B
(zh)
*
|
2016-07-19 |
2020-03-27 |
上海勋和医药科技有限公司 |
Bet蛋白抑制剂及其应用
|
|
EP3490552B1
(en)
|
2016-07-26 |
2022-11-23 |
University of Southern California |
Selective bromodomain inhibition of fungal bdf1
|
|
EP3858837A1
(en)
|
2016-09-13 |
2021-08-04 |
The Regents of The University of Michigan |
Fused 1,4-diazepines as bet protein degraders
|
|
WO2018052945A1
(en)
|
2016-09-13 |
2018-03-22 |
The Regents Of The University Of Michigan |
Fused 1,4-oxazepines as bet protein degraders
|
|
CN109906223A
(zh)
|
2016-10-04 |
2019-06-18 |
英安塔制药有限公司 |
异噁唑类似物作为fxr激动剂及其使用方法
|
|
US10597391B2
(en)
|
2016-10-26 |
2020-03-24 |
Enanta Pharmaceuticals, Inc. |
Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof
|
|
CN108069976A
(zh)
|
2016-11-10 |
2018-05-25 |
山东罗欣药业集团股份有限公司 |
一种含氮大环类化合物、其制备方法、药物组合物及应用
|
|
US10398706B2
(en)
|
2017-01-06 |
2019-09-03 |
Enanta Pharmaceuticals, Inc. |
Heteroaryldiazepine derivatives as RSV inhibitors
|
|
US11046709B2
(en)
|
2017-02-03 |
2021-06-29 |
The Regents Of The University Of Michigan |
Fused 1,4-diazepines as BET bromodomain inhibitors
|
|
EP3582784B1
(en)
|
2017-02-16 |
2022-06-08 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of benzodiazepine derivatives
|
|
CN108727380A
(zh)
*
|
2017-04-13 |
2018-11-02 |
中国科学院上海药物研究所 |
一种brd4抑制剂及其制备和应用
|
|
CN110418791B
(zh)
*
|
2017-04-28 |
2022-07-01 |
四川科伦博泰生物医药股份有限公司 |
包含苯并二氮䓬类化合物的注射用组合物及其制备方法
|
|
CN108948018B
(zh)
*
|
2017-05-17 |
2021-03-30 |
四川科伦博泰生物医药股份有限公司 |
苯并二氮*衍生物及其盐和相关晶体形式、制备方法和用途
|
|
WO2018226801A1
(en)
|
2017-06-07 |
2018-12-13 |
Enanta Pharmaceuticals, Inc. |
Aryldiazepine derivatives as rsv inhibitors
|
|
WO2019006295A1
(en)
|
2017-06-30 |
2019-01-03 |
Enanta Pharmaceuticals, Inc. |
HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
|
|
WO2019006291A1
(en)
|
2017-06-30 |
2019-01-03 |
Enanta Pharmaceuticals, Inc. |
HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
|
|
WO2019055444A1
(en)
|
2017-09-13 |
2019-03-21 |
The Regents Of The University Of Michigan |
DEGRADATION AGENTS OF BROMODOMAIN BET PROTEIN WITH CLEAR BINDERS
|
|
WO2019056950A1
(zh)
*
|
2017-09-22 |
2019-03-28 |
南京明德新药研发股份有限公司 |
噻吩并二氮杂卓衍生物及其应用
|
|
WO2019067864A1
(en)
|
2017-09-29 |
2019-04-04 |
Enanta Pharmaceuticals, Inc. |
PHARMACEUTICAL AGENTS IN COMBINATION AS INHIBITORS OF RSV
|
|
CA3080138A1
(en)
|
2017-11-13 |
2019-05-16 |
Enanta Pharmaceuticals, Inc. |
Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
|
|
WO2019094920A1
(en)
|
2017-11-13 |
2019-05-16 |
Enanta Pharmaceuticals, Inc. |
Azepin-2-one derivatives as rsv inhibitors
|
|
US10689391B2
(en)
|
2017-12-12 |
2020-06-23 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as FXR agonists and methods of use thereof
|
|
WO2019160813A1
(en)
|
2018-02-14 |
2019-08-22 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2019199908A1
(en)
|
2018-04-11 |
2019-10-17 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as rsv inhibitors
|
|
WO2020177762A1
(zh)
*
|
2019-03-07 |
2020-09-10 |
南京明德新药研发有限公司 |
同时具有BET Bromodomain蛋白抑制和PD-L1基因调控作用的化合物
|
|
MX2021011144A
(es)
|
2019-03-18 |
2022-01-18 |
Enanta Pharm Inc |
Derivados de las benzodiazepinas como inhibidores del vsr.
|
|
WO2020210246A1
(en)
|
2019-04-09 |
2020-10-15 |
Enanta Pharmaceuticals, Inc, |
Heterocyclic compounds as rsv inhibitors
|
|
GB201905721D0
(en)
|
2019-04-24 |
2019-06-05 |
Univ Dundee |
Compounds
|
|
US11555032B2
(en)
|
2019-05-13 |
2023-01-17 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as FXR agonists and methods of use thereof
|
|
MX2022003984A
(es)
|
2019-10-04 |
2022-07-27 |
Enanta Pharm Inc |
Compuestos heterociclicos antivirales.
|
|
US11505558B1
(en)
|
2019-10-04 |
2022-11-22 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
PT116050B
(pt)
*
|
2020-01-09 |
2022-06-15 |
Hovione Farm S A |
Conjugados fármaco-ligando e inibidores das proteínas da família bromodomínio e domínio extraterminal -(bet) modificados
|
|
UY39032A
(es)
|
2020-01-24 |
2021-07-30 |
Enanta Pharm Inc |
Compuestos heterocíclicos como agentes antivirales
|
|
WO2021175432A1
(en)
|
2020-03-04 |
2021-09-10 |
Boehringer Ingelheim International Gmbh |
Method for administration of an anti cancer agent
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
TW202219056A
(zh)
|
2020-06-23 |
2022-05-16 |
美商建南德克公司 |
巨環化合物及其使用方法
|
|
US11534439B2
(en)
|
2020-07-07 |
2022-12-27 |
Enanta Pharmaceuticals, Inc. |
Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
|
|
US11945824B2
(en)
|
2020-10-19 |
2024-04-02 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as anti-viral agents
|
|
GB202016977D0
(en)
|
2020-10-26 |
2020-12-09 |
In4Derm Ltd |
Compounds
|
|
CN114456171A
(zh)
*
|
2020-11-09 |
2022-05-10 |
中国药科大学 |
一类用于镇静催眠的苯并二氮䓬类药物、其制备方法及应用
|
|
CN112358483A
(zh)
*
|
2020-11-09 |
2021-02-12 |
中国药科大学 |
一类新型苯并二氮*类化合物、其制备方法及其用途
|
|
US11945830B2
(en)
|
2021-02-26 |
2024-04-02 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
GB2621505B
(en)
|
2021-06-29 |
2024-07-03 |
Tay Therapeutics Ltd |
Pyrrolopyridone derivatives useful in the treatment of inflammatory disorders, immune disorders and cancer
|
|
WO2023205251A1
(en)
|
2022-04-19 |
2023-10-26 |
Nuevolution A/S |
Compounds active towards bromodomains
|
|
WO2024018423A1
(en)
|
2022-07-21 |
2024-01-25 |
Tay Therapeutics Limited |
Pyrroles and imidazoles as bet protein inhibitors
|
